File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/0002-9378(93)90027-G
- Scopus: eid_2-s2.0-0027376874
- PMID: 8238149
- WOS: WOS:A1993MC45800026
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Contractile effect of endothelin in human placental veins: Role of endothelium prostaglandins and thromboxane
Title | Contractile effect of endothelin in human placental veins: Role of endothelium prostaglandins and thromboxane |
---|---|
Authors | |
Keywords | Endothelin-1 placental vein prostaglandins thromboxanes |
Issue Date | 1993 |
Publisher | Mosby, Inc. The Journal's web site is located at http://www.elsevier.com/locate/ajog |
Citation | American Journal Of Obstetrics And Gynecology, 1993, v. 169 n. 4, p. 919-924 How to Cite? |
Abstract | Objective: The aim was to study the effects of endothelin-1 on human placental veins and the role of cyclooxygenase products as mediators of these effects. Study design: Rings of placental veins with and without endothelium were suspended in organ chambers filled with physiologic salt solution. After a period of stabilization at optimal basal tension, isometric tensions in the control group were recorded at increasing concentrations of endothelin-1 (10-10 to 10-7 mol/L). Rings in the experimental groups were treated with either indomethacin (cyclooxygenase inhibitor, 10-5 mol/L), dazoxiben (thromboxane synthetase inhibitor, 10-4 mol/L), or SQ29548 (thromboxane receptor antagonist 10-6 mol/L) before addition of endothelin-1. To demonstrate the presence of functional thromboxane receptors in the rings, contractile responses to U-46619 (10-9 to 10-6 mol/L), a thromboxane A2 analog were measured. The effectiveness of SQ29548 blockade was tested in rings treated with SQ29548 (10-6 mol/L) before addition of U-46619. The concentration-response curves of the treated and control groups were compared with the Student paired t test. Results: Endothelin-1 in doses of 10-10 to 10-7 mol/L caused concentration-dependent contraction of placental veins. Indomethacin significantly reduced the response of veins with endothelium to low endothelin-1 concentrations (10-9.5 to 10-9 mol/L), (p < 0.05). However, it had no effect at higher endothelin-1 concentrations or in vessels without endothelium. The presence of functional thromboxane A2 receptors was confirmed by the vasoconstrictor effect of U-46619 and its blockade by treatment with SQ29548. Neither SQ29548 nor the thromboxane A2 synthesis inhibitor dazoxiben significantly influenced the response to endothelin-1. Conclusions: These results demonstrated that endothelin-1 is a potent vasoconstrictor in the human placental vein. Although functional thromboxane A2 receptors exist in this vessel, endothelin-1 is action is independent of thromboxane A2. Prostaglandins may mediate part of the endothelin-1-induced placental vasoconstriction. However, endothelin-1 acts primarily by a direct effect on vascular smooth muscle cells. |
Persistent Identifier | http://hdl.handle.net/10722/171099 |
ISSN | 2023 Impact Factor: 8.7 2023 SCImago Journal Rankings: 3.024 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Le, SQ | en_US |
dc.contributor.author | Wasserstrum, N | en_US |
dc.contributor.author | Mombouli, JV | en_US |
dc.contributor.author | Vanhoutte, PM | en_US |
dc.date.accessioned | 2012-10-30T06:12:11Z | - |
dc.date.available | 2012-10-30T06:12:11Z | - |
dc.date.issued | 1993 | en_US |
dc.identifier.citation | American Journal Of Obstetrics And Gynecology, 1993, v. 169 n. 4, p. 919-924 | en_US |
dc.identifier.issn | 0002-9378 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/171099 | - |
dc.description.abstract | Objective: The aim was to study the effects of endothelin-1 on human placental veins and the role of cyclooxygenase products as mediators of these effects. Study design: Rings of placental veins with and without endothelium were suspended in organ chambers filled with physiologic salt solution. After a period of stabilization at optimal basal tension, isometric tensions in the control group were recorded at increasing concentrations of endothelin-1 (10-10 to 10-7 mol/L). Rings in the experimental groups were treated with either indomethacin (cyclooxygenase inhibitor, 10-5 mol/L), dazoxiben (thromboxane synthetase inhibitor, 10-4 mol/L), or SQ29548 (thromboxane receptor antagonist 10-6 mol/L) before addition of endothelin-1. To demonstrate the presence of functional thromboxane receptors in the rings, contractile responses to U-46619 (10-9 to 10-6 mol/L), a thromboxane A2 analog were measured. The effectiveness of SQ29548 blockade was tested in rings treated with SQ29548 (10-6 mol/L) before addition of U-46619. The concentration-response curves of the treated and control groups were compared with the Student paired t test. Results: Endothelin-1 in doses of 10-10 to 10-7 mol/L caused concentration-dependent contraction of placental veins. Indomethacin significantly reduced the response of veins with endothelium to low endothelin-1 concentrations (10-9.5 to 10-9 mol/L), (p < 0.05). However, it had no effect at higher endothelin-1 concentrations or in vessels without endothelium. The presence of functional thromboxane A2 receptors was confirmed by the vasoconstrictor effect of U-46619 and its blockade by treatment with SQ29548. Neither SQ29548 nor the thromboxane A2 synthesis inhibitor dazoxiben significantly influenced the response to endothelin-1. Conclusions: These results demonstrated that endothelin-1 is a potent vasoconstrictor in the human placental vein. Although functional thromboxane A2 receptors exist in this vessel, endothelin-1 is action is independent of thromboxane A2. Prostaglandins may mediate part of the endothelin-1-induced placental vasoconstriction. However, endothelin-1 acts primarily by a direct effect on vascular smooth muscle cells. | en_US |
dc.language | eng | en_US |
dc.publisher | Mosby, Inc. The Journal's web site is located at http://www.elsevier.com/locate/ajog | en_US |
dc.relation.ispartof | American Journal of Obstetrics and Gynecology | en_US |
dc.subject | Endothelin-1 | - |
dc.subject | placental vein | - |
dc.subject | prostaglandins | - |
dc.subject | thromboxanes | - |
dc.subject.mesh | 15-Hydroxy-11 Alpha,9 Alpha-(Epoxymethano)Prosta-5,13-Dienoic Acid | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Endothelins - Pharmacology | en_US |
dc.subject.mesh | Endothelium, Vascular - Drug Effects - Physiology | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Hydrazines - Pharmacology | en_US |
dc.subject.mesh | Imidazoles - Pharmacology | en_US |
dc.subject.mesh | Indomethacin - Pharmacology | en_US |
dc.subject.mesh | Placenta - Blood Supply | en_US |
dc.subject.mesh | Pregnancy | en_US |
dc.subject.mesh | Prostaglandin Endoperoxides, Synthetic - Pharmacology | en_US |
dc.subject.mesh | Prostaglandin-Endoperoxide Synthases - Physiology | en_US |
dc.subject.mesh | Prostaglandins - Pharmacology | en_US |
dc.subject.mesh | Thromboxane A2 - Antagonists & Inhibitors - Physiology | en_US |
dc.subject.mesh | Thromboxane-A Synthase - Antagonists & Inhibitors | en_US |
dc.subject.mesh | Vasoconstriction - Drug Effects | en_US |
dc.subject.mesh | Vasoconstrictor Agents - Pharmacology | en_US |
dc.subject.mesh | Veins | en_US |
dc.title | Contractile effect of endothelin in human placental veins: Role of endothelium prostaglandins and thromboxane | en_US |
dc.type | Article | en_US |
dc.identifier.email | Vanhoutte, PM:vanhoutt@hku.hk | en_US |
dc.identifier.authority | Vanhoutte, PM=rp00238 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/0002-9378(93)90027-G | - |
dc.identifier.pmid | 8238149 | - |
dc.identifier.scopus | eid_2-s2.0-0027376874 | en_US |
dc.identifier.volume | 169 | en_US |
dc.identifier.issue | 4 | en_US |
dc.identifier.spage | 919 | en_US |
dc.identifier.epage | 924 | en_US |
dc.identifier.isi | WOS:A1993MC45800026 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Le, SQ=7006184502 | en_US |
dc.identifier.scopusauthorid | Wasserstrum, N=7004673923 | en_US |
dc.identifier.scopusauthorid | Mombouli, JV=7004285772 | en_US |
dc.identifier.scopusauthorid | Vanhoutte, PM=7202304247 | en_US |
dc.identifier.issnl | 0002-9378 | - |